Abstract
摘要
相似文献
1
[Pseudomonas aeruginosa infections].[铜绿假单胞菌感染]
Naika. 1972;29(2):286-90.
2
[Sensitivity in vitro to antibiotics and chemotherapeutic agents in various hospital strains of Pseudomonas aeruginosa].[不同医院分离的铜绿假单胞菌菌株对抗生素和化疗药物的体外敏感性]
Boll Ist Sieroter Milan. 1974 Jan-Feb;50(1):45-53.
3
[Does a rational therapeutic plan exist for nosocomial bacteremia caused by Pseudomonas aeruginosa?].对于铜绿假单胞菌引起的医院获得性菌血症是否存在合理的治疗方案？
Med Clin (Barc). 1987 Oct 24;89(13):572.
4
[In vitro/in vivo discrepancy of antibiotic activity against Pseudomonas aeruginosa].[抗生素对铜绿假单胞菌活性的体外/体内差异]
Fortschr Med. 1985 Sep 12;103(34):807-10.
5
[Metallo-beta-lactamases producing Pseudomonas aeruginosa in Algeria].
Med Mal Infect. 2009 Jun;39(6):413-4. doi: 10.1016/j.medmal.2008.11.001. Epub 2008 Dec 25.
6
[Trend of therapy in Pseudomonas aeruginosa infections].
G Mal Infett Parassit. 1971 Nov;23(11):1051-4.
7
[Role of antibiotics in infections due to Pseudomonas aeruginosa].
Cesk Epidemiol Mikrobiol Imunol. 1972 Jul;21(4):176-81.
8
Stable carbapenem susceptibility rates among multidrug-resistant Acinetobacter spp. strains in a setting of high prevalence of carbapenem-resistant Pseudomonas aeruginosa.在耐碳青霉烯类铜绿假单胞菌高流行率背景下，多重耐药不动杆菌属菌株中碳青霉烯类药物的敏感性稳定率。
Int J Antimicrob Agents. 2007 Aug;30(2):187-9. doi: 10.1016/j.ijantimicag.2007.03.001. Epub 2007 Apr 23.
9
Colistin: an antimicrobial for the 21st century?黏菌素：21世纪的抗菌药物？
Clin Infect Dis. 2002 Oct 1;35(7):901-2. doi: 10.1086/342570.
10
Impact of dissimilar susceptibility breakpoints for doripenem on susceptibility and carbapenem discordance for Pseudomonas aeruginosa.多黏菌素B对铜绿假单胞菌敏感性及碳青霉烯类药物不一致性的不同药敏折点的影响
Diagn Microbiol Infect Dis. 2009 Aug;64(4):465-7. doi: 10.1016/j.diagmicrobio.2009.03.017. Epub 2009 Apr 25.
Zotero 插件